NCT00898313: Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer |
|
|
| Recruiting | N/A | 4000 | US | comparative genomic hybridization, gene expression microarray analysis, proteomic profiling analysis, biologic sample preservation procedure, nasal brushing, Blood draw, Urine collection, sputum sample, fluorescence bronchoscopy with airway biopsy, fine needle aspiration of the lung, thoracentesis | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Lung Cancer | 01/25 | 01/25 | | |
NCT04165564: DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers |
|
|
| Active, not recruiting | N/A | 85 | US | Institutional standard of care, Biosamples of airway and blood | Boston University, Johnson & Johnson, American College of Radiology Imaging Network | Pulmonary Disease | 12/26 | 12/26 | | |
DECAMP-2, NCT02504697: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer |
|
|
| Active, not recruiting | N/A | 665 | US | Biosamples from airway and blood | Boston University, American College of Radiology Imaging Network | Pulmonary Disease | 12/27 | 12/27 | | |
